About Algentics

🌟 Our Mission

To advance precision medicine through AI, modelling, and lab science, delivering faster, more personalized, and affordable treatment decisions to expand access for everyone who needs it.

🔭 Our Vision

A world where precision therapies are not only smart and effective, but also accessible, powered by AI to reduce treatment costs and make personalized care available to all.

Company Narrative

Algentics is a Canadian scientific company founded by experts in AI, immunology, and biomedical research. We combine in silico modeling with wet-lab validation to support smarter treatment decisions—helping researchers and clinicians translate complex biological data into real-world impact.

🧬 Our Story

Algentics was born at the intersection of two scientific worlds, a shared vision.

Dr. Ahmad Abboud, a specialist in Artificial Intelligence and Machine Learning with a deep passion for biology, and Dr. Zeinab Dalloul, an expert in Oncology and Immunology with a strong interest in emerging technologies, first crossed paths during their PhD studies at the Université de Limoges in France. Years later, their professional journeys converged again in Canada, where both pursued postdoctoral research in their respective fields—AI and Life Sciences, each driven by a commitment to impact patient care.

It was during this time that the idea for Algentics took form: to combine their complementary expertise and build a platform where AI meets biology, not just in theory, but in practice.

With a shared belief that technology should reduce the cost of care and improve access to life-saving treatments, they co-founded Algentics to bring advanced in silico modelling, wet lab validation, and AI-enabled decision support to life sciences, hospitals, and research institutions.

At Algentics, their knowledge came together—and so did their mission.